EP232: Why the Right KPIs Are Vital to Improve Patient/Customer Experience, With Jon Skinner From The Verde Group
Relentless Health ValueJune 20, 2019
232
26:2736.32 MB

EP232: Why the Right KPIs Are Vital to Improve Patient/Customer Experience, With Jon Skinner From The Verde Group

It is pretty much inarguable that happy customers are a prerequisite for business success. And that’s true in health care as much as it’s true in every other industry—although in health care, sometimes the customer is also called a patient.

Provider organizations like Cleveland Clinic are really walking the walk when it comes to creating amazing patient/customer experiences; so are other leading provider organizations. But in other segments of the health care industry, maybe they haven’t quite connected the dots between the idea of satisfying customer needs in the abstract and then what that actually looks like relative to a strategic approach.

Let me give you an example—certainly not all pharmaceutical manufacturers: Here’s where key performance indicators, or KPIs, come in. Everything we do should really be derived from what customers need and expect. This could be considered our North Star. And that’s why creating KPIs that focus on how well we are doing delivering on great customer experiences over the long run delivers superior market returns and patient outcomes and patient satisfaction.

My guest today on the podcast is Jon Skinner, who is an executive vice president at The Verde Group. Jon’s message is that your KPIs—if they are done right, in any case—should tell you if you are delivering on a set of customer expectations that are going to lead you to your vision of what success looks like. The Verde Group is a market research firm that specializes in quantifying the customer experience, in case you have not heard of them. I met Jon, by the way, at the PanAgora Pharma CX conference this past spring.

By the way, in this interview, the acronym HCP is used. In case you are unfamiliar, HCP stands for health care professional and it can mean anyone from a physician to a nurse to any other advanced practice clinician.

You can learn more at verdegroup.com.

Jon Skinner is executive vice president with The Verde Group, a customer experience (CX) research consultancy focusing on the financial quantification of customer experiences. Jon works with market leaders across the pharmaceutical and health care space to help them identify the specific customer experiences most consequential to revenue and share growth, and then to develop CX improvements that sustainably grow customer value, build brand equity, and develop customer-centric cultures. Jon started his CX career at Digitas, where he led the Customer Management Group and advised clients on customer value management, loyalty strategy, and channel execution. His general management experience includes executive leadership positions at Excite@Home, Webroot Software, and New England Business Services. Jon holds an MBA from the Amos Tuck School of Business at Dartmouth.


02:48 Quantifying the customer experience and KPIs.
03:19 “What behavior change do you want to stimulate?”
03:29 Two overarching strategic outcomes.
04:41 How a pharma or health care entity correlates a CX improvement to a social outcome.
06:18 “You need to have a thoughtful portfolio.”
08:16 Examples of nonintuitive creativity.
11:53 Conspiring purposefully or by accident to create patient experiences.
14:42 Responding to changing conditions in real time.
15:14 “You can’t go wrong.”
16:06 KPIs are incredibly powerful and potentially damaging when tied to rewards.
16:28 Being thoughtful of compensation programs.
16:51 Why adherence is an important focus.
21:42 Experiences, quantifying experience, KPIs, changing customer experience, and achieving new outcomes.
22:33 “The best place to focus is on what’s going wrong.”

Podcast,care,digital,health,healthcare,marketing,reimbursement,tech,the verde group,customer experience,

Recent Episodes

EP468: Very Common Assumptions That Aren’t Actually True About Member Engagement and the Healthcare Industry, With Matt McQuide
March 20, 2025
468
34:3931.72 MB

EP468: Very Common Assumptions That Aren’t Actually True About Member Engagement and the Healthcare Industry, With Matt McQuide

This conversation today with Matt McQuide is such a follow-on to the episode from last week where I encapsulated a major theme from the past five or six episodes. I know I’m on a roll. The thing is, if an employer doesn’t take the initiative and steer members or help them navigate through our curre...

EP467: Connecting Sky-High ER Spend to Primary Care Access—Following the Dollar Through Carriers and Hospitals, With Stacey Richter
March 13, 2025
467
23:0921.19 MB

EP467: Connecting Sky-High ER Spend to Primary Care Access—Following the Dollar Through Carriers and Hospitals, With Stacey Richter

Here’s my new idea for an episode. Welcome to it. I want to talk about a major theme running through the last few episodes of Relentless Health Value. And this theme is, heads up, going to continue through a few upcoming shows as well. For a full transcript of this episode, click here . If you enjo...

EP466: What Is Rising Faster, Insurance Premiums or Hospital Prices? With Vivian Ho, PhD
March 06, 2025
466
36:1233.13 MB

EP466: What Is Rising Faster, Insurance Premiums or Hospital Prices? With Vivian Ho, PhD

This episode has three chapters. Each one answers a key question, and, bottom line, it all adds up to action steps directly and indirectly for many, including plan sponsors probably, community leaders, and also hospital boards of directors. Here’s the three chapters in sum. For a full transcript of...

EP465: The Not Super Effective Contracting Industry Norm, Where Jumbo Plans and Others Wind Up Paying $10,000 for $50 Drugs, With Chris Crawford
February 27, 2025
465
34:1531.34 MB

EP465: The Not Super Effective Contracting Industry Norm, Where Jumbo Plans and Others Wind Up Paying $10,000 for $50 Drugs, With Chris Crawford

First of all, everybody listening here has probably heard of the lawsuit in which J&J—and talking about J&J as a large employer here now, not as a drug company—but J&J is (or maybe was, there’s action afoot) being sued by a plan member because, here’s the short version, allegedly, the J...

EP464: ER Visits Now 6% of Total Plan Spend. Is It Upcoding or What? With Al Lewis
February 20, 2025
494
31:4028.99 MB

EP464: ER Visits Now 6% of Total Plan Spend. Is It Upcoding or What? With Al Lewis

Today, I am speaking with the one, the only Al Lewis, and we’re gonna talk about how 6% of a lot of plan sponsors’ total spend is now going to ER/ED (emergency room/emergency department) visits. That’s a lot of spend. For a full transcript of this episode, click here . If you enjoy this podcast, be...

EP463: Medicare Advantage Policies—Which Will Stay and Which Will Go Now? With Betsy Seals
February 13, 2025
463
35:1132.2 MB

EP463: Medicare Advantage Policies—Which Will Stay and Which Will Go Now? With Betsy Seals

Every Gen X’er listening to this is gonna be singing that Clash  song in your head for the rest of the day. So, let’s turn our attention to Medicare Advantage policy. And on the show today, I grill the one and only Betsy Seals to find out which policies she thinks are going to stay and which a...

Encore! EP384: How Shareholders Impact Carrier Behavior, Exactly and Specifically, With Wendell Potter
February 06, 202535:0132.05 MB

Encore! EP384: How Shareholders Impact Carrier Behavior, Exactly and Specifically, With Wendell Potter

I am drowning in all things Q1 right now. So, this week we’re going with an encore. But this is a great show to go back and reflect upon, as it’s about carriers and how shareholders impact the actions of said carriers. For a full transcript of this episode, click here . If you enjoy this podcast, b...

Listen and Follow

Sponsored by Aventria Health Group
©2025 BD Bridges LLC. All Rights Reserved.